Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

terminated133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

MRI Study of Cerebral Blood Flow in Development Disorders in Children

NCT02165410
terminatednot_applicable

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma

NCT04831138
completed

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

NCT01727622

Clinical Trials (3)

Showing 3 of 3 trials
NCT02165410Not Applicable

MRI Study of Cerebral Blood Flow in Development Disorders in Children

Completed
NCT04831138Not Applicable

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma

Terminated
NCT01727622

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3